TY - JOUR
T1 - The use of artificial intelligence to aid the diagnosis of lung cancer – A retrospective-cohort study
AU - Tugwell-Allsup, J. R.
AU - Owen, B. W.
AU - Hibbs, R.
AU - England, A.
N1 - Publisher Copyright:
© 2025 The College of Radiographers
PY - 2025/3
Y1 - 2025/3
N2 - Introduction: AI software in the form of deep learning–based automatic detection (DLAD) algorithms for chest X-ray (CXR) interpretation have shown success in early detection of lung cancer (LC), however, there remains uncertainty related to clinical validation. Methods: CXRs and their corresponding chest-CT scans were retrospectively collated from a single institution between January 2019–2020. A commercially available AI software was used to evaluate 320 CXRs (<6 years prior-to-diagnosis) from 105 positive LC patients and 103 negative controls. Clinical reports were extracted and coded to correlate against AI findings. Results: Of 105 LC patients, (57[55 %] men, median [IQR] age 73[68–83] years), clinical reports identified LC in 64 (61 %) whereas AI identified LC in 95 (90 %). AI diagnostic (image-level) and prognostic (patient-level) sensitivities were 57.6 % and 90.0 %, (81 % in correct location), respectively. On CXRs performed >12 months prior to LC diagnosis, the AI detected nodules in 24(23 %) cases of which 22/24 had negative clinical reports for lung nodule/mass. The potential median reduction in time-to-diagnosis for cases where AI identified nodule(s) on previous CXR, but clinical reports negative, was 193[IQR 42–598] days. Of the 103 ‘negative’ controls (48[47 %] men, median [IQR] age 69[61–77] years) 20 patients had a nodule abnormality score above the threshold, generating a false-positive rate of 19 %. Conclusion: The AI software showed excellent performance in detecting LCs that initially went undetected on CXR. The algorithm has potential to increase LC detection rates and reduce time-to-diagnosis. Using the AI, in conjunction with a trained observer, could increase reporting accuracy and potentially improve clinical outcomes. Implications for practice: This study demonstrated the benefits and pitfalls associated with using AI in a clinical setting. It provides further evidence for utilising decision-support aids within clinical practice.
AB - Introduction: AI software in the form of deep learning–based automatic detection (DLAD) algorithms for chest X-ray (CXR) interpretation have shown success in early detection of lung cancer (LC), however, there remains uncertainty related to clinical validation. Methods: CXRs and their corresponding chest-CT scans were retrospectively collated from a single institution between January 2019–2020. A commercially available AI software was used to evaluate 320 CXRs (<6 years prior-to-diagnosis) from 105 positive LC patients and 103 negative controls. Clinical reports were extracted and coded to correlate against AI findings. Results: Of 105 LC patients, (57[55 %] men, median [IQR] age 73[68–83] years), clinical reports identified LC in 64 (61 %) whereas AI identified LC in 95 (90 %). AI diagnostic (image-level) and prognostic (patient-level) sensitivities were 57.6 % and 90.0 %, (81 % in correct location), respectively. On CXRs performed >12 months prior to LC diagnosis, the AI detected nodules in 24(23 %) cases of which 22/24 had negative clinical reports for lung nodule/mass. The potential median reduction in time-to-diagnosis for cases where AI identified nodule(s) on previous CXR, but clinical reports negative, was 193[IQR 42–598] days. Of the 103 ‘negative’ controls (48[47 %] men, median [IQR] age 69[61–77] years) 20 patients had a nodule abnormality score above the threshold, generating a false-positive rate of 19 %. Conclusion: The AI software showed excellent performance in detecting LCs that initially went undetected on CXR. The algorithm has potential to increase LC detection rates and reduce time-to-diagnosis. Using the AI, in conjunction with a trained observer, could increase reporting accuracy and potentially improve clinical outcomes. Implications for practice: This study demonstrated the benefits and pitfalls associated with using AI in a clinical setting. It provides further evidence for utilising decision-support aids within clinical practice.
KW - AI
KW - Chest X-ray
KW - DLAD
KW - Lung cancer
UR - https://www.scopus.com/pages/publications/85216693710
U2 - 10.1016/j.radi.2025.01.011
DO - 10.1016/j.radi.2025.01.011
M3 - Article
C2 - 39890480
AN - SCOPUS:85216693710
SN - 1078-8174
VL - 31
JO - Radiography
JF - Radiography
IS - 2
M1 - 102876
ER -